News & Events about Sigilon Therapeutics Inc.
Canaccord Genuity Group initiated coverage on shares of Sigilon Therapeutics (NASDAQ:SGTX Get Rating) in a research note released on Wednesday, Benzinga reports. The brokerage issued a buy rating and a $6.00 price target on the stock. Sigilon Therapeutics Price Performance NASDAQ:SGTX opened at $0....
Ticker Report
4 months ago
Canaccord Genuity Group initiated coverage on shares of Sigilon Therapeutics (NASDAQ:SGTX Get Rating) in a research note released on Wednesday, Benzinga reports. The brokerage issued a buy rating and a $6.00 price target on the stock. Sigilon Therapeutics Price Performance NASDAQ:SGTX opened...
Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner PR Newswire CAMBRIDGE, Mass., April 13, 2022 CAMBRIDGE, Mass., April 13, 2022 /PRNewswire/ -- Flagship...
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022 Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022 Ranks #2 Most Innovative Company in North America PR Newswire CAMBRIDGE, Mass., March...
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs PR Newswire CAMBRIDGE, Mass., Feb. 28, 2022...